SRx Health Solutions Income Statement (2010-2025) | SRXH

1Y3Y5Y7Y10YAll
Download Data
Income Statement Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue (Quarter)
9.29M10.83M10.99M13.20M10.99M17.01M16.52M11.87M9.27M9.24M10.54M13.12M5.70M7.90M42.67M11.37M19.20M7.16M11.45M
Cost of Revenue (Quarter)
19.64M6.55M7.09M8.76M8.23M12.31M11.79M7.70M7.60M6.00M6.95M8.68M5.17M5.29M33.25M6.85M-12.03M4.78M8.03M
Gross Profit (Quarter)
3.37M4.28M3.90M4.44M2.76M4.71M4.73M4.17M1.66M3.24M3.59M4.44M0.53M2.61M9.42M4.52M31.22M2.38M3.42M
Operating items
Depreciation & Amortization - Total (Quarter)
Selling, General & Administrative (Quarter)
11.33M6.89M6.77M7.75M7.11M7.58M8.99M10.57M7.21M6.50M6.17M7.05M4.72M5.08M10.74M5.64M3.47M18.15M
Other Operating Expenses (Quarter)
-4.95M2.52M0.33M0.66M0.62M1.09M18.61M8.53M-0.46M15.48M-6.15M
Operating Expenses (Quarter)
6.38M9.41M7.10M8.40M7.73M8.67M8.99M10.57M25.82M6.50M6.17M7.05M13.26M5.08M10.74M5.64M15.48M3.47M20.84M
Operating Income (Quarter)
-3.01M-5.14M-3.20M-3.97M-4.98M-3.96M-4.26M-6.40M-24.16M-3.25M-2.58M-2.62M-12.72M-2.47M-1.32M-1.13M8.51M-1.09M-17.42M
EBIT (Quarter)
-3.01M-5.14M-3.20M-3.97M-4.98M-3.96M-4.26M-6.40M-24.16M-3.25M-2.58M-2.62M-12.72M-2.47M-1.32M-1.13M8.51M-1.09M-17.42M
Non-operating items
Non Operating Investment Income (Quarter)
0.10M
Other Non Operating Income (Quarter)
-26.77M-7.71M27.97M0.51M-0.07M-0.08M-0.11M-0.23M-0.23M-0.38M0.99M-0.36M0.12M2.65M0.04M0.02M
Non Operating Income (Quarter)
-26.77M-7.71M27.97M0.51M-0.07M-0.08M-0.11M-0.14M-0.23M-0.23M-0.38M0.99M-0.36M0.12M2.65M0.13M0.02M
Net income details
EBT (Quarter)
-3.01M-12.85M24.78M-3.46M-5.05M-4.04M-4.37M-6.55M-24.38M-3.48M-2.96M-1.62M-14.70M-2.83M-2.33M1.52M8.51M-0.96M-16.69M
Tax Provisions (Quarter)
0.04M0.00M0.00M-0.02M0.10M0.10M0.01M-0.01M0.00M0.34M-0.00M0.07M0.00M0.10M
Profit After Tax (Quarter)
-29.78M-12.85M24.78M-3.46M-5.08M-4.04M-4.37M-6.55M-24.36M-3.48M-2.96M-1.62M-14.70M-2.83M-3.10M1.53M-3.98M-0.96M-15.10M
Income from Continuing Operations (Quarter)
-3.01M-12.85M24.78M-3.46M-5.08M-4.04M-4.37M-6.55M-24.36M-3.58M-3.06M-1.63M-14.69M-2.83M-2.68M1.53M8.44M-0.96M-16.79M
Consolidated Net Income (Quarter)
-3.01M-12.85M24.78M-3.46M-5.08M-4.04M-4.37M-6.55M-24.36M-3.58M-3.06M-1.63M-14.69M-2.83M-2.68M1.53M-3.98M-0.96M-16.79M
Income towards Parent Company (Quarter)
-3.01M-12.85M24.78M-3.46M-5.08M-4.04M-4.37M-6.55M-24.36M-3.58M-3.06M-1.63M-14.69M-2.83M-2.68M1.53M-3.98M-0.96M-16.79M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-29.78M-12.85M24.78M-3.46M-5.08M-4.04M-4.37M-6.55M-24.36M-3.48M-2.96M-1.62M-14.70M-2.83M-2.68M1.53M-3.98M-0.96M-16.79M
Additional items
EPS (Basic) (Quarter)
-3.61-1.382.23-0.12-0.33-0.14-0.15-0.22-58.42-5.03-4.27-2.30-20.85-3.60-0.140.73-0.17-0.37-0.74
EPS (Weighted Average and Diluted) (Quarter)
-3.61-1.381.19-0.12-0.20-0.14-0.15-0.22-58.42-5.03-4.27-2.30-20.85-3.60-0.140.73-0.17-0.37-0.74
Shares Outstanding (Weighted Average) (Quarter)
9.92M9.59M10.36M16.80M19.93M29.29M29.33M29.36M0.67M0.69M0.69M0.70M0.71M0.79M22.01M22.08M23.58M2.61M19.33M21.11M
Shares Outstanding (Diluted Average) (Quarter)
8.18M9.59M21.39M23.69M21.90M29.29M29.33M29.36M0.67M0.69M0.69M0.70M0.71M0.79M22.01M22.08M23.58M2.61M19.33M21.11M
EBITDA (Quarter)
-3.01M-5.14M-3.20M-3.97M-4.98M-3.96M-4.26M-6.40M-24.16M-3.25M-2.58M-2.62M-12.72M-2.47M5.79M-1.13M8.51M-1.09M-26.92M
Interest Expenses (Quarter)
0.23M0.38M0.36M0.18M
Tax Rate (Quarter)
-0.73%-0.07%-0.02%0.09%-2.87%-3.37%-0.62%0.05%-0.07%-14.78%-0.13%0.87%-0.21%-0.60%